High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Over the past six months, Agilent’s stock price fell to $134.31. Shareholders have lost 8.2% of their capital, which is disappointing considering the S&P 500 has climbed by 8.4%. This may have investors wondering how to approach the situation.
Investor expectations are high heading into the earnings season, leaving lots of room for disappointment. Consensus estimates signal S&P 500 earnings to grow 22% from the year-ago period, that’s after more than 27% growth in the first quarter, Bank of America reported. “Expectations are elevated, but we see no signs of earnings momentum rolling over,” Bank of America strategists said, issuing an earnings forecast that sat above consensus estimates and lifting their full-year EPS outlook.
Wall Street is expecting a tranquil earnings season.
Financial markets started the week on an uncertain note as renewed military tensions between the United States and Iran pushed oil prices sharply higher, pressured equity futures and shifted investor attention toward a crucial week of corporate earnings. At the same time, weakness across Asian semiconductor stocks has prompted questions about near-term sentiment toward artificial intelligence investments, despite continued strong demand for advanced chips.
Investing.com - Renewed fighting between the United States and Iran rattled markets at the start of the week, sending oil prices sharply higher and weighing on stock futures.
Insperity currently trades at $44.35 per share and has shown little upside over the past six months, posting a small loss of 2%. The stock also fell short of the S&P 500’s 7.2% gain during that period.
Over the last six months, Coupang’s shares have sunk to $19.11, producing a disappointing 13.8% loss - a stark contrast to the S&P 500’s 7.2% gain. This might have investors contemplating their next move.
B. Riley Wealth chief market strategist Art Hogan shares his outlook for this earnings season and the opportunities he sees in Big Tech, while Yahoo Finance Markets and Data Editor Jared Blikre discusses what recent Hindenburg Omens may be signaling for US markets (^DJI, ^IXIC, ^GSPC).
By Ragini Mathur and Avinash P July 10 (Reuters) - Wall Street indexes steadied on Friday, as investors awaited the highly anticipated Nasdaq debut of South Korean chip bellwether SK Hynix, shifting
Kingdom Capital Advisors, a registered investment advisor, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. In Q2 2026, Kingdom Capital Advisors’ KCA Value Composite returned 11.97% net of fees. YTD, the composite returned 20.94% net of fees compared to 22.57% for the Russell 2000 TR, 10.18% for the […]
By Lewis Krauskopf NEW YORK, July 10 (Reuters) - An eventful coming week of economic data, corporate earnings reports and Middle East developments will test a resilient U.S. stock market that has
The company also topped analyst estimates, but that clearly wasn't good enough for Mr. Market.
Expectations are high for Q2 earnings reports from several major companies.
PepsiCo stock was falling Thursday after the soft drinks and snacks maker said it had lost market share in North America, overshadowing a second-quarter earnings beat. The maker of Lay’s, Doritos, Pepsi, and Gatorade reported an adjusted profit of $2.20 a share for the second quarter, as revenue climbed 6.4% from a year ago to $24.18 billion. Analysts were expecting adjusted earnings of $2.19 a share on revenue of $23.95 billion, according to a FactSet poll.
Amgen trades at $365.22 per share and has stayed right on track with the overall market, gaining 12% over the last six months. At the same time, the S&P 500 has returned 7.7%.
Limbach has been treading water for the past six months, recording a small loss of 1.9% while holding steady at $77.06. The stock also fell short of the S&P 500’s 7.7% gain during that period.
The airline kicks off earnings season Friday. Is the stock worth buying ahead of it?
Since July 2021, the S&P 500 has delivered a total return of 74.3%. But one standout stock has nearly doubled the market - over the past five years, OFG Bancorp has surged 140% to $49.88 per share. Its momentum hasn’t stopped as it’s also gained 19.7% in the last six months thanks to its solid quarterly results, beating the S&P by 10.8%.
Over the past six months, HCA Healthcare’s stock price fell to $423.55. Shareholders have lost 11.6% of their capital, which is disappointing considering the S&P 500 has climbed by 9%. This might have investors contemplating their next move.
Over the last six months, Ameresco’s shares have sunk to $25.63, producing a disappointing 12.5% loss - a stark contrast to the S&P 500’s 9% gain. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Progyny trades at $31.10 per share and has stayed right on track with the overall market, gaining 13.4% over the last six months. At the same time, the S&P 500 has returned 9%.
Bank stocks have enjoyed a nice run overall, and valuations are now fairly elevated.
S&P 500 companies are expected to report 23.3% earnings growth for Q2, the second straight quarter above 20% and far above the average growth rate of 16.4% over the past five years, according to FactSet. The key question for markets, according to famed investment strategist Ed Yardeni, is whether analysts got carried away after Q1 earnings and set the bar too high. "The big risk up ahead is that technology companies, especially the hyperscalers, won't beat analysts' overly optimistic earnings growth estimates for the quarter," Yardeni wrote in Monday note.
M&T Bank’s 14.5% return over the past six months has outpaced the S&P 500 by 6.5%, and its stock price has climbed to $239.99 per share. This run-up might have investors contemplating their next move.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
